Community Health Interventions | Thalassemia
16394
page,page-id-16394,page-template-default,ajax_fade,page_not_loaded,,qode-theme-ver-7.9,wpb-js-composer js-comp-ver-4.9.1,vc_responsive
 

Thalassemia

What Should You Know About Thalassemia?

Thalassemia is a group of genetic blood disorders that affect approximately 1,000 individuals in the United States. The most severe of these disorders is Cooley’s Anemia.

 

People with thalassemia have a genetic defect of their red blood cells that affects the cells’ ability to produce normal hemoglobin. Red blood cells use hemoglobin to carry oxygen to tissues. As a result of the defect, most forms of thalassemia produce a chronic, lifelong anemia that begins in early childhood and often must be treated with frequent transfusions.

 

Prevention Activities

CDC is developing a new program to establish a surveillance system to monitor blood safety for thalassemia patients, establish a network of specialized health-care centers to promote the management, treatment, and prevention of complications experienced by persons with thalassemia. For more information?

 

Organizations

 

  • National Heart Lung and Blood Institute
  • Cooley’s Anemia Foundation icon
  • Thalassaemia International Federation
  • Kids Health
  • Related Pages
  • Deep Vein Thrombosis (DVT) and Clotting
  • Diamond Blackfan Anemia
  • Hemochromatosis (Iron Overload)
  • Hemophilia
  • Sickle Cell Disease
  • Women’s Blood Disorders
  • CDC’s National Center on Birth Defects and Developmental Disabilities

 

Content source: Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention